Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Rapport Therapeutics Inc (RAPP)

158 + Investors. Track Smart Money conviction in RAPP. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +15
Streak
9Q ▲
Buyers last Q
58%

Smart Money Signals — RAPP

Based on 160 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 9 quarters in a row

last 6Q
For 9 consecutive quarters, more hedge funds added RAPP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
160 hedge funds hold RAPP right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +98% more funds vs a year ago

fund count last 6Q
+79 new funds entered over the past year (+98% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 58% buying

88 buying63 selling
Last quarter: 88 funds bought or added vs 63 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~32 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 51 → 40 → 29 → 32. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 41% entered in last year

■ 12% conviction (2yr+) ■ 47% medium ■ 41% new
Only 20 funds (12%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +32% but shares only +0% — price-driven

Value
+32%
Shares
+0%
Last quarter: the total dollar value of institutional holdings rose +32%, but actual share count only changed +0%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📊

Peak discovery — momentum slowing

14 → 51 → 40 → 29 → 32 new funds/Q
New funds entering each quarter: 51 → 40 → 29 → 32. RAPP is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🌱

Early stage — 56% of holders entered in last year

■ 5% veterans ■ 39% 1-2yr ■ 56% new
Of 163 current holders: 91 (56%) entered in the past year, only 8 (5%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
🏆

Elite ownership — 44% AUM from top-100 funds

44% from top-100 AUM funds
44 of 160 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in RAPP. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.7
out of 10
Moderate Exit Risk
Exit risk score 4.7/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — RAPP

In 2026 Q2, 88 hedge funds were net buyers of RAPP (32 opened a new position, 56 added to an existing one), while 63 reduced or exited (46 trimmed, 17 sold completely) — a 58% buyer ratio, indicating a slight buying edge. This marks 9 consecutive quarters of net institutional buying — a persistent conviction signal. 44% of total institutional value in RAPP is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +15 funds (more new holders than closures). Total institutional holders: 160.

Hedge Fund Ownership: RAPP

How many hedge funds hold RAPP — quarterly history vs. share price
Quarterly hedge fund ownership of RAPP vs. share price

Market Analysis: RAPP

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: RAPP

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Rapport Therapeutics Inc (RAPP) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much RAPP has moved relative to its sector benchmark (XLV) since the 2026 Q3 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End September 30, 2026 · 45d ago
RAPP
-20.4%
XLV
+11.8%

RAPP outperformed XLV by -32.2% since September 30, 2026.

Since 13F Filing Date November 14, 2026 · 0d ago
RAPP
+0.0%
XLV
+0.0%

Since the filing became public, RAPP outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

10 top-rated funds 4 high-conviction
Consensus
4.5
/ 10
breadth
×
Elite
3.0
/ 10
conviction
Hedge Fund Positioning: RAPP
2026 Q3 Stats Unlock in 5 days 158 + Investors

Track Smart Money conviction in RAPP. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 158 145 8.97%
13F Shares 51M 52M -2.36%
Total Value $2.08B $1.59B 30.36%
New Positions 32 29 +3
Increased Positions 55 52 +3
Closed Positions 19 27 -8
Reduced Positions 45 34 +11
Total Calls 1 1 -
Total Puts 2 1 100.0%
PUT/CALL Ratio 2.0 1.0 Bearish

Statistics: RAPP

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q3)

158 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in RAPP. Verified SEC 13F-HR filings.

QUARTER:
2026 Q3 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 RAPP holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Johnson & Johnson 7.87% 1,784,517 $60.0M
2 Siren, L.L.C. 0.51% 641,469 $21.6M
3 AlphaCentric Advisors LLC 0.20% 6,752 $227K
4 Kennedy Capital Management LLC 0.16% 251,912 $8.5M
5 Catalyst Private Wealth, LLC 0.14% 10,046 $338K
6 Silverarc Capital Management, LLC 0.14% 35,524 $1.2M
7 Integrated Quantitative Investments LLC 0.06% 10,688 $359K
8 Virtus Investment Advisers, LLC 0.06% 8,264 $278K
9 Clear Wave Wealth Management LLC 0.06% 9,500 $319K
10 Candriam S.C.A. 0.05% 346,696 $11.7M
11 Profund Advisors LLC 0.03% 33,112 $1.1M
12 Artisan Partners Limited Partnership 0.03% 437,608 $14.7M
13 China Universal Asset Management Co., Ltd. 0.03% 15,154 $500K
14 Sigma Planning Corp 0.03% 30,000 $1.0M
15 Capital International Investors 0.02% 2,653,640 $89.2M
16 Fmr LLC 0.01% 7,196,657 $241.8M
17 Alps Advisors Inc 0.01% 63,565 $2.1M
18 Tidemark, LLC 0.01% 1,088 $37K
19 Ensign Peak Advisors, Inc 0.01% 126,780 $4.3M
20 Quadrature Capital Ltd 0.01% 28,318 $951K
21 Quantbot Technologies LP 0.00% 3,533 $119K
22 Swedbank AB 0.00% 117,400 $3.9M
23 State of Wyoming 0.00% 1,013 $34K
24 Ameritas Investment Partners, Inc. 0.00% 2,780 $93K
25 Nomura Asset Management Co Ltd 0.00% 36,795 $1.2M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Rapport Therapeutics Inc (RAPP)

What does the Smart Money Trend signal show for RAPP?

Buying streak — 9 quarters in a row: For 9 consecutive quarters, more hedge funds added RAPP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for RAPP?

Slight buying edge — 58% buying: Last quarter: 88 funds bought or added vs 63 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for RAPP holders?

Elite ownership — 44% AUM from top-100 funds: 44 of 160 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in RAPP. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held RAPP?

Mostly new holders — 41% entered in last year: Only 20 funds (12%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Rapport Therapeutics Inc (RAPP) following the 2026 Q3 hedge fund 13F filings?

As of today, RAPP has moved +0.0% since the 2026 Q3 13F filing date (November 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (September 30, 2026), RAPP has gained -20.4% vs +11.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →